Pertussis in Poland in 2016

Agnieszka Rumik1, Iwona Paradowska-Stankiewicz1, Jolanta Rudowska1

  • 1National Institute of Public Health - National Institute of Hygiene in Warsaw, Department of Epidemiology of Infectious Diseases and Surveillance

Przeglad Epidemiologiczny
|November 6, 2018
PubMed

Insights

Pertussis (whooping cough) incidence increased by 38% in Poland in 2016, highlighting ongoing bacterial circulation. Vaccination remains the most effective strategy to prevent pertussis outbreaks.

Area of Science:

  • Epidemiology
  • Public Health
  • Infectious Diseases

Background:

  • Pertussis incidence in Poland has remained high for a decade, with a significant 38% increase in 2016 compared to the previous year.
  • Older individuals with pertussis pose a risk of infection to unvaccinated or under-vaccinated infants and newborns.

Purpose of the Study:

  • To evaluate the 2016 epidemiological situation of pertussis in Poland.
  • To compare the 2016 pertussis data with previous years.
  • To assess the vaccination status of children against pertussis.

Main Methods:

  • Analysis of individual suspected pertussis case reports submitted to NIZP-PZH.
  • Review of national data from "Infectious diseases and poisoning in Poland in 2016" bulletin.
  • Examination of data from the "Protective vaccinations in Poland in 2016" bulletin.

Main Results:

  • In 2016, 6,828 pertussis cases were recorded, with an incidence rate of 17.77 per 100,000 population.
  • The highest incidence was observed in the 10-14 age group (88.1 per 100,000), with high rates also in infants aged 0 and 3 years.
  • 24% of pertussis patients (1,640 individuals) were hospitalized; no deaths were reported in 2016.

Conclusions:

  • The rise in pertussis cases in 2016 indicates continued bacterial circulation and population susceptibility.
  • Maintaining high vaccination coverage according to the current schedule is crucial for reducing pertussis incidence.
  • Vaccination remains the primary and most effective strategy for pertussis prevention.
Abstract

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...